Leech-transmitted ciprofloxacin-resistant Aeromonas hydrophila

Eric W. Wang, David K. Warren, Vicky M. Ferris, Ed Casabar, Brian Nussenbaum

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

The use of medicinal leeches (Hirudo medicinalis) is effective in establishing venous outflow in congested flaps and replants.1,2 Leech therapy also has associated risks, including significant blood loss requiring transfusions and infections from Aeromonas, a gram-negative bacilli.2 Leeches maintain a symbiotic relationship with Aeromonas species, which are resident to their gut in order to digest blood. Aeromonas hydrophila infections can result in extensive soft-tissue infections and myonecrosis.3 To prevent this devastating nosocomial infection, ciprofloxacin and/or trimethoprim-sulfamethoxazole (TMP-SMX) are the most commonly used prophylactic antibiotics when patients undergo leech therapy.1,4

Original languageEnglish
Pages (from-to)190-193
Number of pages4
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume137
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint Dive into the research topics of 'Leech-transmitted ciprofloxacin-resistant Aeromonas hydrophila'. Together they form a unique fingerprint.

  • Cite this